Skip to content
DilutionScan
MoneyHero Ltd logo
MNY$0.56-2.10%

MoneyHero Ltd

Sector: Services-Business Services, NECIndustry: Internet Content & InformationCountry: SGExchange: Nasdaq

Mkt Cap$17.46M
Float & O/S15.33M / 31.18M
Inst Own1.6%

DilutionScan read 36 of MoneyHero Ltd's SEC filings and found 5 warrant series, 1 convertible and 1 S-1 registration on file for MNY. The latest dilution event on file is a registration statement on Jan 22, 2024. Analysis updated Oct 4, 2026.

Signal8 Summary

MNY

Nasdaq deficiency, activist pressure, shrinking revenue

Snapshot

MoneyHero is a tiny personal-finance comparison platform with FY 2025 revenue of $73.4M, down 7.7% YoY, and a $5.2M net loss. Gross margin is a healthy 49%, so the losses stem from operating costs, not broken unit economics.

What's Happening Right Now

  • : MoneyHero launched critical illness insurance comparison on its Hong Kong marketplace, adding 13 plans from five insurers as part of its push into higher-margin insurance products.
  • : Jonathan Honig disclosed a 9.0% stake and publicly demanded MoneyHero's Board hire an independent advisor and explore a sale, citing a six-month CEO vacancy and an 88% share-price decline, valuing the company at $1.50+ per share.
  • : Q2 2026 revenue fell 13% YoY to $15.8M and the company swung to a $1.2M net loss, though adjusted EBITDA losses narrowed sharply and the company ended the quarter debt-free with $28.2M cash.
  • : MoneyHero received a Nasdaq deficiency letter on August 7, 2026 for trading below $1.00 for 30 straight days, with until February 3, 2027 to regain compliance.
  • : MoneyHero's Philippines platform Moneymax partnered with EastWest Bank to let consumers compare and apply for personal loans on its platform.
  • : Registered additional securities for sale on Form S-1.
  • : Issued warrants over 26.28M shares across 2 series.
  • : Issued warrants over 6.16M shares across 3 series.

DilutionScan ProEvery instrument in full · $59/mo